The Rise of Big Data Registries in Rheumatology – Part 1

Michael George, MD, is an assistant professor of rheumatology and epidemiology at the University of Pennsylvania. His research is focused on comparative medication safety, especially infection risk with different immunosuppressive agents.

Jeff Greenberg, MD, is the chief medical officer at CorEvitas and a clinical associate professor of medicine at the New York University (NYU) Grossman School of Medicine. He also sees patients at the Institute for Rheumatic and Autoimmune Diseases at Overlook Hospital in Summit, New Jersey. Dr Greenberg was previously the associate director of clinical and translational sciences in the Division of Rheumatology at the NYU Grossman School of Medicine. Dr Greenberg’s major research interests focus on the pharmacoepidemiology of advanced therapies, including comparative effectiveness research and drug safety research. Prior to receiving his MD degree at McGill University in Canada, he studied economics and history at the University of Pennsylvania. He completed a fellowship training in rheumatology at NYU Hospital for Joint Diseases. Dr Greenberg has been the recipient of numerous awards, including the Physician Scientist Development Award from the American College of Rheumatology (ACR) and the Clinical Translational Research Award from the Arthritis Foundation. In addition, his work has been funded by the National Institute of Health (NIH), the Agency for Healthcare Research and Quality (AHRQ), and the Arthritis National Research Foundation.